Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Skye Bioscience Inc SKYE

Healthcare Biotechnology
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company... see more

Current News (NDAQ:SKYE)

Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire 5 days ago

Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026

GlobeNewswire 11 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Skye Bioscience, Inc. (SKYE) and Encourages Shareholders to Learn More About the Investigation

ACCESS Newswire February 19, 2026

Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

ACCESS Newswire February 17, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Skye Bioscience, Inc. (SKYE) Shareholders to Inquire about Securities Investigation

ACCESS Newswire February 15, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Skye Bioscience, Inc. (SKYE) And Encourages Shareholders to Connect

ACCESS Newswire February 12, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Skye Bioscience, Inc. (SKYE) Stockholders to Inquire about Securities Investigation

ACCESS Newswire February 10, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Skye Bioscience, Inc. (SKYE) and Encourages Investors to Learn More About the Investigation

ACCESS Newswire February 8, 2026

Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire February 5, 2026
View More News ››

Opinion & Analysis (NDAQ:SKYE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SKYE)

Great news

Great news we're off the OTC and on the Nasdaq tomorrow morning April 11!! https://stockhouse.com/news/press-releases/2024/04/10/skye...
snowtrac - April 10, 2024

Cannabinoid Manufacturing

Worth skipping to minute 29:30: https://youtu.be/44fFn8aD3Zo
Bullknit101 - October 8, 2021

Press release

Punit Dhillon..you should do a press release how successful you and your uncle are by stealing shareholder money!
Stockqueen77 - August 9, 2021

RE:The arrest of AVTAR DHILLON

Punit Dhillon sat as a director of Arch Therapeutics...wonder if he'll be sitting beside his uncle and his mentor Avtar Dhillon, the...
Stockqueen77 - August 5, 2021

The arrest of AVTAR DHILLON

Cannabis and Biotech Board Chair Arrested for Securities Fraud BY BRE BRADHAM Aug. 5, 2021, 8:47 AM Listen A cannabis and biotechnology...
Stockqueen77 - August 5, 2021

Where is this company located

Where are they conducting these trials?...maybe Punit the CEO can answer this question if hes not to busy training or writing a book.
Stockqueen77 - July 14, 2021
View more Bullboard ››

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp

Pinnacle Silver and Gold Corp., an exploration stage company, engages in the acquisition and exploration of mineral ...
View More »

Podcasts